Brainsway Deep TMS Therapy - for Brain Disorder Treatment

References

Trademarks

Brainsway and the Brainsway logo are trademarks of Brainsway LTD.

Efficacy of Brainsway Deep TMS for Depression

Levkovitz Y, Harel EV, Roth Y et al. Deep transcranial magnetic stimulation of the prefrontal cortex—Effectiveness in major depression. Brain Stimul 2009;2:188–200.

Isserles M, Rosenberg O, Dannon P et al. Cognitive emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcomes. J Affect Disord 2011;128:235–42.

Harel EV, Rabany L, Deutsch L, Bloch Y, Zangen A, Levkovitz Y. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study. World J Biol Psychiatry. 2014 May;15(4):298-306.

Rosenberg O, Zangen A, Stryjer R et al. Response to deep TMS in depressive patients with previous electroconvulsive treatment. Brain Stimul 2010;3:211–217.

Rosenberg O, Shoenfeld N, Zangen A et al. Deep TMS in a resistant major depressive disorder: A brief report. DepressAnxiety 2010;27:465–469.

Rosenberg O, Isserles M, Levkovitz Y et al. Effectiveness of a second deep TMS in depression: A brief report. Prog Neuropsychopharmacol Biol Psychiat 2011;35:1041–1044.

Levkovitz Y, Isserles M, Padberg F, Lisanby SH, Bystritsky A, Xia G, Tendler A, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry 2015;14(1):64-73.

Harvey PO, Van den Eynde F, Zangen A, Berlim MT. Neural correlates of clinical improvement after deep transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a case report using functional magnetic resonance imaging. Neurocase. 2015;21(1):16-22.

Berlim MT, Van den Eynde F, Tovar-Perdomo S, Chachamovich E, Zangen A, Turecki G. Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression. World J Biol Psychiatry. 2014;15(7):570-578.

Multicenter trial leading to Brainsway's FDA Clearance for Treating Depression

Levkovitz Y. et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective, multi-center, randomized, controlled trial. World Psychiatry, 2015; Vol.14, 64-73.

Efficacy of Brainsway Deep TMS for Bipolar disorder

Harel EV, Zangen A, Roth Y, Reti I, Braw Y, Levkovitz Y. H-coil repetitive transcranial magnetic stimulation for the treatment of bipolar depression: an add-on, safety and feasibility study. World J Biol Psychiatry 2011;12:119-126.

Efficacy of Brainsway Deep TMS for PTSD

Isserles M, Shalev AY, Roth Y, Peri T, Kutz I, Zlotnick E, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder - A pilot study. Brain Stimul 2013;6:377-383.

Efficacy of Brainsway Deep TMS for Negative Symptoms in Schizophrenia

Levkovitz Y, Rabany L., Harel EV and Zangen A. Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: A feasibility study. Int. J. Neuropsychopharm2011;14:991-996.

Efficacy of Brainsway Deep TMS for Autism

Enticott PG, Fitzgibbon BM, Kennedy HA, et al. A Double-blind, Randomized Trial of Deep Repetitive Transcranial Magnetic Stimulation (rTMS) for Autism Spectrum DisorderBrain Stimul 2014;7:206-211.

Efficacy of Brainsway Deep TMS for Chronic Pain

Onesti E, Gabriele M, Cambieri C, Ceccanti M, Raccah R, Di Stefano G, BiasiottaA, Truini A, Zangen A, Inghilleri M. H-coil repetitive transcranial magnetic stimulation for pain relief in patients with diabetic neuropathy. Eur J Pain. 2013;17(9):1347-1356.

Efficacy of Brainsway Deep TMS for Stroke Rehabilitation

Chieffo R1, Ferrari F, Battista P, et al. Excitatory deep transcranial magnetic stimulation with H-coil over the right homologous Broca's region improves naming in chronic post-stroke aphasia. Neurorehabil Neural Repair 2014;28:291-298.

Chieffo R, De Prezzo S, Houdayer E, et al. Deep repetitive transcranial magnetic stimulation with H-coil on lower limb motor function in chronic stroke: a pilot study. Arch Phys Med Rehabil 2014;95(6):1141-1147.

Efficacy of Brainsway Deep TMS for Parkinson’s Disease

Spagnolo F, Volonté MA, Fichera M, et al. Excitatory deep repetitive transcranial magnetic stimulation with H-coil as add-on treatment of motor symptoms in Parkinson's disease: an open label, pilot study. Brain Stimul 2014;7:297-300.

Efficacy of Brainsway Deep TMS for Smoking Cessation

Dinur-Klein L, Dannon P, Hadar A, et al. Smoking Cessation Induced by Deep Repetitive Transcranial Magnetic Stimulation of the Prefrontal and Insular Cortices: A Prospective, Randomized Controlled Trial. Biol Psychiatry 2014;76(9):742-749.

Tolerance and Side Effects of Brainsway Deep TMS

Levkovitz Y. et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective, multi-center, randomized, controlled trial. World Psychiatry, 2015; Vol.14, 64-73.

Levkovitz Y, Harel EV, Roth Y, Braw Y, Sheer A Katz L, Gersner R and Zangen A. (2009) Deep transcranial magnetic stimulation of the prefrontal cortex – Effectiveness in major depression. Brain Stimulation 2: 188-200. 

Isserles M, Rosenberg O, Dannon P, Lerer B and Zangen A (2011) Cognitive emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcomes. Journal of Affective Disorders 128: 235-242.

Harel EV, Rabany L, Deutsch L, Bloch Y, Zangen A, Levkovitz Y. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study. World J Biol Psychiatry 2014;15(4):298-306.

Efficacy of Antidepressants

Rush AJ, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–1917.

Side Effects of Antidepressants

Fabbri C, Marsano A, Balestri M, De Ronchi D, Serretti A. Clinical features and drug induced side effects in early versus late antidepressant responders. J Psychiatr Res 2013;47(10):1309-1318.

Risks and Side effects of ECT

Lawrence Park, AM, MD. (2011). Risks and Side Effects of ECT. Psych Central. Retrieved on December 3, 2014, from http://psychcentral.com/lib/risks-and-side-effects-ofect/0007365

Prevalence of Depression

Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R).  Archives of General Psychiatry 2005;62(6):617-627.

Brainsway's FDA Clearance

FDA 510(k) No. K122288

Click to view FDA Clearance

Brainsway's CE Approval

Annex II of MDD 93/42/EEC

ISO 13485:2012

Click  to view CE Approval according to Annex II of Guideline 93/42/EEC and ISO 13485:2012 Certificate

Deep brain structures' connections with other reward systems

Leh SE, Ptito A, Chakravarty MM, Strafella AP. Fronto-striatal connections in the human brain: a probabilistic diffusion tractography study. Neurosci Lett 2007;419:113-118.


© Brainsway Ltd.® 2014 | All rights reserved. Patients Portal · Brainsway Deep TMS · FDA Clearance · Disclaimer · Privacy Policy · Terms of Use